Sunshine Biopharma Inc.Sunshine Biopharma Inc.Sunshine Biopharma Inc.

Sunshine Biopharma Inc.

No trades
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪5.79 M‬USD
−1.8608USD
‪−5.13 M‬USD
‪34.87 M‬USD
‪4.90 M‬
Beta (1Y)
3.74

About Sunshine Biopharma Inc.


CEO
Steve N. Slilaty
Headquarters
Fort Lauderdale
Founded
2006
Identifiers
3
ISIN US8677815024
Sunshine Biopharma, Inc. is a pharmaceutical company, which engages in the research, development, and commercialization of oncology and antiviral drugs. It is also involved in the development and commercialization of science-based nutritional supplements. The firm's product includes treatment for Coronavirus infections and anticancer drugs. The company was founded on August 31, 2006 and is headquartered in Fort Lauderdale, FL.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Displays a symbol's price movements over previous years to identify recurring trends.